142 related articles for article (PubMed ID: 24827837)
1. Nanomedicine for the treatment of triple-negative breast cancer.
Kutty RV; Wei Leong DT; Feng SS
Nanomedicine (Lond); 2014 Apr; 9(5):561-4. PubMed ID: 24827837
[No Abstract] [Full Text] [Related]
2. Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers.
Kutty RV; Feng SS
Biomaterials; 2013 Dec; 34(38):10160-71. PubMed ID: 24090836
[TBL] [Abstract][Full Text] [Related]
3. Lipid-enveloped hybrid nanoparticles for drug delivery.
Tan S; Li X; Guo Y; Zhang Z
Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
[TBL] [Abstract][Full Text] [Related]
4. The holistic 3M modality of drug delivery nanosystems for cancer therapy.
Sun J; Luo C; Wang Y; He Z
Nanoscale; 2013 Feb; 5(3):845-59. PubMed ID: 23292001
[TBL] [Abstract][Full Text] [Related]
5. Applications of nanomedicine in breast cancer detection, imaging, and therapy.
Saadeh Y; Leung T; Vyas A; Chaturvedi LS; Perumal O; Vyas D
J Nanosci Nanotechnol; 2014 Jan; 14(1):913-23. PubMed ID: 24730308
[TBL] [Abstract][Full Text] [Related]
6. Loading Lovastatin into Camptothecin-Floxuridine Conjugate Nanocapsules for Enhancing Anti-metastatic Efficacy of Cocktail Chemotherapy on Triple-negative Breast Cancer.
Zhang N; Liang X; Gao C; Chen M; Zhou Y; Krueger CJ; Bao G; Gong Z; Dai Z
ACS Appl Mater Interfaces; 2018 Sep; 10(35):29385-29397. PubMed ID: 30096224
[TBL] [Abstract][Full Text] [Related]
7. Triple-negative breast cancer: molecular subtypes and targeted therapy.
Hirshfield KM; Ganesan S
Curr Opin Obstet Gynecol; 2014 Feb; 26(1):34-40. PubMed ID: 24346128
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine and nanotoxicology: the pros and cons for neurodegeneration and brain cancer.
Catalan-Figueroa J; Palma-Florez S; Alvarez G; Fritz HF; Jara MO; Morales JO
Nanomedicine (Lond); 2016 Jan; 11(2):171-87. PubMed ID: 26653284
[TBL] [Abstract][Full Text] [Related]
9. Challenges for metals in medicine: how nanotechnology may help to shape the future.
Barry NP; Sadler PJ
ACS Nano; 2013 Jul; 7(7):5654-9. PubMed ID: 23837396
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanocapsules: a new platform for nanomedicine.
Huynh NT; Passirani C; Saulnier P; Benoit JP
Int J Pharm; 2009 Sep; 379(2):201-9. PubMed ID: 19409468
[TBL] [Abstract][Full Text] [Related]
11. The in vivo performance of ferrocenyl tamoxifen lipid nanocapsules in xenografted triple negative breast cancer.
Lainé AL; Adriaenssens E; Vessières A; Jaouen G; Corbet C; Desruelles E; Pigeon P; Toillon RA; Passirani C
Biomaterials; 2013 Sep; 34(28):6949-56. PubMed ID: 23777919
[TBL] [Abstract][Full Text] [Related]
12. Tretinoin-loaded lipid-core nanocapsules overcome the triple-negative breast cancer cell resistance to tretinoin and show synergistic effect on cytotoxicity induced by doxorubicin and 5-fluororacil.
Schultze E; Buss J; Coradini K; Begnini KR; Guterres SS; Collares T; Beck RCR; Pohlmann AR; Seixas FK
Biomed Pharmacother; 2017 Dec; 96():404-409. PubMed ID: 29031198
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells.
Gao J; Li W; Guo Y; Feng SS
Nanomedicine (Lond); 2016 Dec; 11(24):3261-3282. PubMed ID: 27854161
[TBL] [Abstract][Full Text] [Related]
14. The role of nanotechnology in gastrointestinal cancer.
Vyas D; Castro P; Saadeh Y; Vyas A
J Biomed Nanotechnol; 2014 Nov; 10(11):3204-18. PubMed ID: 26000381
[TBL] [Abstract][Full Text] [Related]
15. Current prospects and challenges of nanomedicine delivery in prostate cancer therapy.
Gupta S; Gupta PK; Dharanivasan G; Verma RS
Nanomedicine (Lond); 2017 Dec; 12(23):2675-2692. PubMed ID: 29098929
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathways: PI3K pathway targets in triple-negative breast cancers.
Gordon V; Banerji S
Clin Cancer Res; 2013 Jul; 19(14):3738-44. PubMed ID: 23748695
[TBL] [Abstract][Full Text] [Related]
17. Targeted nanotherapeutics in cancer.
Shiekh FA
Int J Nanomedicine; 2014; 9():1627-8. PubMed ID: 24741302
[No Abstract] [Full Text] [Related]
18. Editorial: Brave new world - Focus on nanomedicine.
Alexiou C; Fadeel B
Biochem Biophys Res Commun; 2015 Dec; 468(3):409-10. PubMed ID: 26518649
[No Abstract] [Full Text] [Related]
19. Themed issue on Cancer Nanotechnology.
Grodzinski P
Integr Biol (Camb); 2013 Jan; 5(1):17-8. PubMed ID: 23179042
[No Abstract] [Full Text] [Related]
20. Nanotechnology applications in diagnosis and treatment of metastasis.
Gupta AS
Nanomedicine (Lond); 2014 Jul; 9(10):1517-29. PubMed ID: 25253499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
